Article
Early Fc-effector antibody signatures impact COVID-19 disease trajectory
2026-02-19
Abstract excerpt
<h4>ABSTRACT</h4> Why do some individuals develop mild COVID-19 while others progress to severe disease remains a central challenge in SARS-CoV-2 immunology. In this study, we leveraged the BACO Cohort – a unique historical cohort of immunologically naïve, hospitalized COVID-19 patients from the first pandemic wave – to investigate early immune determinants of clinical disease trajectories. Integrating bulk RNA-s...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3cc2bc61-c98b-5788-a778-efee4a85d8e9
- DOI
- 10.64898/2026.02.18.26346542
